Gold nanoparticles for safe delivery of cisplatin

Yoray Sharon; Menachem Motiei; Chen Tzror-Azankot; Tamar Sadan; Rachela Popovtzer; Eli Rosenbaum

doi:10.1117/12.3005425

Gold nanoparticles for safe delivery of cisplatin

Yoray Sharon
, Menachem Motiei
, Chen Tzror-Azankot
, Tamar Sadan
, Rachela Popovtzer
, Eli Rosenbaum

Bar-Ilan University - The Alexander Kofkin Faculty of Engineering

Rabin Medical Center Israel
Bar-Ilan University

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Abstract

Cisplatin (CP) is the primary standard treatment for bladder cancer. Nevertheless, CP has side effects, particularly nephrotoxicity. This limits the treatment of a notable portion of advanced bladder cancer patients with cisplatin. We have developed gold nanoparticles that conjugate CP (CP-AuNPs) for safer delivery to tumors. Here, we investigated the biodistribution of the CP-AuNP conjugates in a mouse model of bladder cancer, to characterize the distinct role of CPAuNP in delivering and releasing CP in tumor and tissues. Effect of the CP-AuNPs on weight and kidney was also investigated. This study can provide insights into the potential safety of CP-AuNP for bladder cancer treatment.

Original language	English
Title of host publication	Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI
Editors	Dror Fixler, Sebastian Wachsmann-Hogiu
Publisher	SPIE
ISBN (Electronic)	9781510669758
DOIs	https://doi.org/10.1117/12.3005425
State	Published - 2024
Event	Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI 2024 - San Francisco, United States Duration: 28 Jan 2024 → …

Publication series

Name	Progress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume	12858
ISSN (Print)	1605-7422

Conference

Conference	Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI 2024
Country/Territory	United States
City	San Francisco
Period	28/01/24 → …

Bibliographical note

Publisher Copyright:
© COPYRIGHT SPIE. Downloading of the abstract is permitted for personal use only.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

biodistribution
cancer
cisplatin-gold nanoparticles

Access to Document

10.1117/12.3005425

Cite this

Sharon, Y., Motiei, M., Tzror-Azankot, C., Sadan, T., Popovtzer, R., & Rosenbaum, E. (2024). Gold nanoparticles for safe delivery of cisplatin. In D. Fixler, & S. Wachsmann-Hogiu (Eds.), Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI Article 128580D (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 12858). SPIE. https://doi.org/10.1117/12.3005425

@inproceedings{162e8ab27c544104be9097662206890a,

title = "Gold nanoparticles for safe delivery of cisplatin",

abstract = "Cisplatin (CP) is the primary standard treatment for bladder cancer. Nevertheless, CP has side effects, particularly nephrotoxicity. This limits the treatment of a notable portion of advanced bladder cancer patients with cisplatin. We have developed gold nanoparticles that conjugate CP (CP-AuNPs) for safer delivery to tumors. Here, we investigated the biodistribution of the CP-AuNP conjugates in a mouse model of bladder cancer, to characterize the distinct role of CPAuNP in delivering and releasing CP in tumor and tissues. Effect of the CP-AuNPs on weight and kidney was also investigated. This study can provide insights into the potential safety of CP-AuNP for bladder cancer treatment.",

keywords = "biodistribution, cancer, cisplatin-gold nanoparticles",

author = "Yoray Sharon and Menachem Motiei and Chen Tzror-Azankot and Tamar Sadan and Rachela Popovtzer and Eli Rosenbaum",

note = "Publisher Copyright: {\textcopyright} COPYRIGHT SPIE. Downloading of the abstract is permitted for personal use only.; Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI 2024 ; Conference date: 28-01-2024",

year = "2024",

doi = "10.1117/12.3005425",

language = "אנגלית",

series = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",

publisher = "SPIE",

editor = "Dror Fixler and Sebastian Wachsmann-Hogiu",

booktitle = "Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI",

address = "ארצות הברית",

}

Sharon, Y, Motiei, M, Tzror-Azankot, C, Sadan, T, Popovtzer, R & Rosenbaum, E 2024, Gold nanoparticles for safe delivery of cisplatin. in D Fixler & S Wachsmann-Hogiu (eds), Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI., 128580D, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 12858, SPIE, Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI 2024, San Francisco, United States, 28/01/24. https://doi.org/10.1117/12.3005425

Gold nanoparticles for safe delivery of cisplatin. / Sharon, Yoray; Motiei, Menachem; Tzror-Azankot, Chen et al.
Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI. ed. / Dror Fixler; Sebastian Wachsmann-Hogiu. SPIE, 2024. 128580D (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 12858).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - Gold nanoparticles for safe delivery of cisplatin

AU - Sharon, Yoray

AU - Motiei, Menachem

AU - Tzror-Azankot, Chen

AU - Sadan, Tamar

AU - Popovtzer, Rachela

AU - Rosenbaum, Eli

PY - 2024

Y1 - 2024

N2 - Cisplatin (CP) is the primary standard treatment for bladder cancer. Nevertheless, CP has side effects, particularly nephrotoxicity. This limits the treatment of a notable portion of advanced bladder cancer patients with cisplatin. We have developed gold nanoparticles that conjugate CP (CP-AuNPs) for safer delivery to tumors. Here, we investigated the biodistribution of the CP-AuNP conjugates in a mouse model of bladder cancer, to characterize the distinct role of CPAuNP in delivering and releasing CP in tumor and tissues. Effect of the CP-AuNPs on weight and kidney was also investigated. This study can provide insights into the potential safety of CP-AuNP for bladder cancer treatment.

AB - Cisplatin (CP) is the primary standard treatment for bladder cancer. Nevertheless, CP has side effects, particularly nephrotoxicity. This limits the treatment of a notable portion of advanced bladder cancer patients with cisplatin. We have developed gold nanoparticles that conjugate CP (CP-AuNPs) for safer delivery to tumors. Here, we investigated the biodistribution of the CP-AuNP conjugates in a mouse model of bladder cancer, to characterize the distinct role of CPAuNP in delivering and releasing CP in tumor and tissues. Effect of the CP-AuNPs on weight and kidney was also investigated. This study can provide insights into the potential safety of CP-AuNP for bladder cancer treatment.

KW - biodistribution

KW - cancer

KW - cisplatin-gold nanoparticles

UR - https://www.scopus.com/pages/publications/85191456276

U2 - 10.1117/12.3005425

DO - 10.1117/12.3005425

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.conference???

AN - SCOPUS:85191456276

T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

BT - Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI

A2 - Fixler, Dror

A2 - Wachsmann-Hogiu, Sebastian

PB - SPIE

T2 - Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI 2024

Y2 - 28 January 2024

ER -

Gold nanoparticles for safe delivery of cisplatin

Abstract

Publication series

Conference

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this